日本語
TOP page
Published papers
Academic conference presentation
(Last updated : 2026-01-22 10:32:33)
NISHIMURA Kouichi
Department
School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine
Position
Clinical Assistant Professor
■
Published papers
1.
Original article
Impact of starting dose of tyrosine kinase inhibitors on outcomes following combination therapy of immune checkpoint inhibitors with tyrosine kinase inhibitors for previously untreated advanced renal cell carcinoma. 2026/01
2.
Original article
Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma. 2025/10
3.
Original article
A case of complete remission of bilateral upper tract carcinoma in situ following retrograde bacillus calmette–guérin (BCG) instillation via open- ended ureteral catheters after failure using Double- J stents. 2025/09/17
4.
Original article
Impact of first-line dual immuno-oncology combination therapy versus immuno-oncology plus tyrosine kinase inhibitor on outcomes of second-line VEGFR-TKI in advanced RCC: a real-world multi-institutional analysis. 2025/09
5.
Original article
Impact of polypharmacy on perioperative outcomes of robot‐assisted laparoscopic partial nephrectomy for small renal masses. 2025/09
6.
Original article
Long-term real-world outcomes of nivolumab plus ipilimumab for advanced renal cell carcinoma: a minimum of 4-years follow-up study. 2025/09
7.
Original article
Effect of age on treatment outcomes of first-line immune checkpoint inhibitor combination therapy for previously untreated advanced renal cell carcinoma. 2025/08
8.
Other
Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. 2025/05
9.
Original article
Comparative analysis of outcomes for patients with advanced renal cell carcinoma: Immuno-oncology era versus tyrosine kinase inhibitor era in the IMDC favorable-risk group. 2025/04
10.
Original article
Changes in outcome of patients with advanced non‑clear cell renal cell carcinoma from the tyrosine kinase inhibitor era
to the immuno‑oncology era. 2024/11
11.
Original article
Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. 2024/09
12.
Original article
First‑line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint
inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the efectiveness using real‑world data. 2024/04
13.
Original article
Assessment of Feasibility of Robot-assistted Radical Cystectomy in Patients With Advanced Bladder Cancer Treated With Maintenance Hemodialysis Therapy 2022
14.
Case report
A case of metastatic Xp11.2 translocation renal cell carcinoma successfully managed by cytoreductive nephrectomy followed by axitinib therapy. 2017/05
Display 5 items
Display all(14)
■
Academic conference presentation
1.
Immunotherapy outcomes and immune microenvironment profiles of patients with non-clear cell renal cell carcinoma. (ポスター掲示,一般) 2025/09/26
2.
Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. (ポスター掲示,一般) 2025/04/27
3.
Evaluation of robot-assisted radical cystectomy with intracorporeal ileal conduit for patients over 80 years of age (一般) 2024/04/27
4.
Therapeutic efficacy of Cabozantinib or Axitinib rechallenge for advanced renal cell carcinoma. (ポスター掲示,一般) 2024/04/27
5.
The retrospective study of upfront cytoreductive nephrectomy for metastatic renal cell carcinoma. (ポスター掲示,一般) 2024/04/25
6.
Investigation of robotic assisted radical prostatectomy in our hospital. (ポスター掲示,一般) 2020/12/22
7.
Clinical and pathological analysis of chronic vascular rejection after renal transplantation. (口頭,一般) 2018/07/21
Display 5 items
Display all(7)